nach oben

Knee Surgery, Sports Traumatology, Arthroscopy

Erschienen in:

01.09.2012 | Knee

The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis

verfasst von: Haoran Zhang, Junmin Chen, Fei Chen, Wenzhong Que

Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Studies have shown that tranexamic acid (TXA) reduces blood loss and transfusion need in patients undergoing total knee arthroplasty (TKA). However, no single study has been large enough to definitively determine whether the drug is safe and effective. We report a systematic review and meta-analysis of randomised controlled trials evaluating the efficacy and safety of TXA in reducing blood loss and transfusion in TKA.

Methods

A comprehensive literature search was done in Cochrane Library, MEDLINE, EMBASE, and CNKI. Two reviewers independently identified the eligible studies, assessed their methodological quality, and extracted data. The data were evaluated using the generic evaluation tool designed by the Cochrane Bone, Joint and Muscle Trauma Group. The relevant data were analyzed using RevMan 5.0.

Results

Fifteen randomized controlled trials involving 842 patients were included. The use of TXA reduced total blood loss by a mean of 487 ml [95% confidence interval (CI) −629 to −344], intra-operative blood loss by a mean of 127 ml (95% CI −313–59), and post-operative blood loss by a mean of 245 ml (95% CI −410 to −80). TXA led to a significant reduction in the proportion of patients requiring blood transfusion (risk difference −0.4). There were no significant differences in deep-vein thrombosis (DVT), pulmonary embolism, or other complications among the study groups.

Conclusion

Meta-analysis indicates that TXA may reduce post-operative, total blood loss and transfusion in patients undergoing TKA. TXA led to a significant reduction in the proportion of patients requiring blood transfusion.

Level of evidence

Therapeutic study (Systematic review of Level I studies with inconsistent results), Level II.

Barwell J, Anderson G, Hassan A, Rawlings I (1997) The effects of early tourniquet release during total knee arthroplasty: a prospective randomized double-blind study. J Bone Joint Surg [Br] 79:265–268CrossRef

Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. J Bone Joint Surg [Br] 78:434–440

Camarasa MA, Ollé G, Serra-Prat M, Martín A et al (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96:576–582PubMedCrossRef

Cardone D, Klein AA (2009) Perioperative blood conservation. Eur J Anaesth 26:722–729CrossRef

Cid J, Lozano M (2005) Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45:1302–1307PubMedCrossRef

Coetzee MJ (2007) The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia. Haemophilia 13:443–444PubMedCrossRef

DeFrances CJ, Podgornik MN (2006) 2004 National hospital discharge survey. Adv Data 4:1–19

Dhillon MS, Bali K, Prabhakar S (2011) Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage. Indian J Orthop 45:148–152PubMedCrossRef

Dietrich W, Spannagl M, Boehm J, Hauner K et al (2008) Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg 107:1469–1478PubMedCrossRef

10.

Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005–1032PubMedCrossRef

11.

Ellis MH, Fredman B, Zohar E, Ifrach N et al (2001) The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 13:509–513PubMedCrossRef

12.

Engel JM, Hohaus T, Ruwoldt R, Menges T et al (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92:775–780PubMedCrossRef

13.

Good L, Peterson E, Lisander B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90:596–599PubMedCrossRef

14.

Handoll H, Elstub L, Elliott J, Stott D et al (2008) Cochrane Bone, Joint and Muscle Trauma Group. About the Cochrane collaboration (Cochrane Review Groups (CRGS)) Issue 4. Art. No: MUSKINJ

15.

Hayes A, Murphy DB, McCarroll M (1996) The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth 8:357–360PubMedCrossRef

16.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef

17.

Hiippala S, Strid L, Wennestrand M, Arvela V et al (1995) Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 74:534–537PubMedCrossRef

18.

Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JVV et al (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839–844PubMed

19.

Ho KM, Ismail H (2003) Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 31:529–537PubMed

20.

Ido K, Neo M, Asada Y, Kondo K et al (2000) Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 120:518–520PubMedCrossRef

21.

Jansen AJ, Andreica S, Claeys M, D’Haese J et al (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83:596–601PubMedCrossRef

22.

Johansson T, Pettersson LG, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money. Acta Orthop 76:314–319PubMed

23.

Kagoma YK, Crowther MA, Douketis J, Bhandari M et al (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopaedic surgery: a systematic review of randomized trials. Thromb Res 123:687–696PubMedCrossRef

24.

Kakar PN, Gupta N, Govil P, Shah V et al (2009) Efficacy and safety of tranexamic acid in control of bleeding following TKR: a randomized clinical trial. Indian J Anaesth 53:667–671PubMed

25.

Kumar A (2009) Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med 76:112–118CrossRef

26.

Lemaire R (2008) Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg [Br] 90:1128–1136CrossRef

27.

Lotke PA, Faralli VJ, Orenstein EM, Ecker ML (1991) Blood loss after total knee replacement: effects of tourniquet release and continuous passive motion. J Bone Joint Surg [Am] 73:1037–1040

28.

Lumsden MA, Wedisinghe L (2011) Tranexamic acid therapy for heavy menstrual bleeding. Expert Opin Pharmacother 12:2089–2095PubMedCrossRef

29.

MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT (2011) Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplast 26:24–28CrossRef

30.

Matziolis D, Perka C, Hube R, Matziolis G (2011) Influence of tourniquet ischemia on perioperative blood loss after total knee arthroplasty. Orthopade 40:178–182PubMedCrossRef

31.

Moher D, Liberati A, Tetzlaff J, Altman DG et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535PubMedCrossRef

32.

Nielsen HJ (1995) Detrimental effects of perioperative blood transfusion. Br J Surg 82:582–587PubMedCrossRef

33.

Niskanen RO, Korkala OL (2005) Tranexamic acid reduces blood loss in cemented hip arthroplasty. Acta Orthop 26:829–832CrossRef

34.

Orpen NM, Little C, Walker G, Crawford EJP (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomized controlled trial of 29 patients. Knee 13:106–110PubMedCrossRef

35.

Phillips B, Ball C, Sackett D, Badenoch D et al (2001) Levels of evidence and grades of recommendations. Oxford Centre for evidence-based medicine levels of evidence. http://www.cebm.net/index.aspx?o=1025

36.

Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg [Br] 91:776–783CrossRef

37.

Rannikko A, Pétas A, Taari K (2004) Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology 64:955–958PubMedCrossRef

38.

Rao SV, Eikelboom JA, Granger CB, Harrington RA et al (2007) Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 28:1193–1204PubMedCrossRef

39.

Tanaka N, Sakahashi H, Sato E, Hirose K et al (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83:702–705PubMedCrossRef

40.

Thorey F, Stukenborg-Colsman C, Windhagen H, Wirth CJ (2008) The effect of tourniquet release timing on perioperative blood loss in simultaneous bilateral cemented total knee arthroplasty: a prospective randomized study. Technol Health Care 16:85–92PubMed

41.

Veien M, Sørensen JV, Madsen F, Juelsgaard P (2002) Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 46:1206–1211PubMedCrossRef

42.

Yang X, Alexander KP, Chen AY, Roe MT et al (2005) The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46:1490–1495PubMedCrossRef

43.

Zanasi S (2011) Innovations in total knee replacement: new trends in operative treatment and changes in peri-operative management. Eur Orthop Traumatol 2:21–31PubMedCrossRef

44.

Zufferey P, Merquiol F, Laporte S, Decousus H et al (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopaedic surgery? Anesthesiology 105:1034–1046PubMedCrossRef

Titel: The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis
verfasst von: Haoran Zhang
Junmin Chen
Fei Chen
Wenzhong Que
Publikationsdatum: 01.09.2012
Verlag: Springer-Verlag
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy / Ausgabe 9/2012
Print ISSN: 0942-2056
Elektronische ISSN: 1433-7347
DOI: https://doi.org/10.1007/s00167-011-1754-z

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Level of evidence

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2012

Letter to the editors

Effects of using a surgical clamp to hold tension while tying knots with commonly used orthopedic sutures

Minimally invasive Unicondylar Knee Arthroplasty in a patellectomized patient

Long-term survival analysis of posterior cruciate-retaining total knee arthroplasty

PRP: more words than facts…